Reduction of skin reactions caused by transdermal drug delivery
    8.
    发明授权
    Reduction of skin reactions caused by transdermal drug delivery 失效
    减少透皮给药引起的皮肤反应

    公开(公告)号:US06203817B1

    公开(公告)日:2001-03-20

    申请号:US09092606

    申请日:1998-06-05

    IPC分类号: A61F1302

    CPC分类号: A61K9/7053 A61K9/7084

    摘要: Transdermal compositions, devices, and methods for the administration of a drug at reduced skin irritation levels are disclosed. More particularly, this invention relates to novel methods, compositions, and devices for the reduction or elimination of irritation or sensitization caused by an irritating or sensitizing drug when it is delivered transdermally. According to a preferred embodiment, transdermal administration of a drug salt of a non-zwitterionic drug is disclosed wherein the drug salt comprises a combination of surface activity and a low octanol-water partition coefficient. Such drug salts have been found to reduce irritation or sensitization to the drug being delivered while achieving therapeutically effective transdermal fluxes.

    摘要翻译: 公开了用于在皮肤刺激水平降低的药物给药的透皮组合物,装置和方法。 更具体地说,本发明涉及当通过皮肤递送时由刺激性或致敏性药物引起的刺激或致敏的减少或消除的新方法,组合物和装置。 根据优选的实施方案,公开了非两性离子药物的药物盐的透皮给药,其中所述药物盐包含表面活性和低辛醇 - 水分配系数的组合。 已经发现,这些药物盐可以减少对所递送药物的刺激或致敏,同时实现治疗有效的经皮通气。

    Transdermal drug delivery devices having coated microprotrusions
    9.
    发明授权
    Transdermal drug delivery devices having coated microprotrusions 有权
    透皮药物递送装置具有包被的微突起

    公开(公告)号:US08663155B2

    公开(公告)日:2014-03-04

    申请号:US11347779

    申请日:2006-02-02

    IPC分类号: A61M37/00

    摘要: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.

    摘要翻译: 提供了用于经皮透皮递送有效药理活性剂的装置(12)和方法。 将试剂溶解在水中以形成具有适当粘度的水性涂料溶液,以涂覆极微小的皮肤刺穿元件(10)。 使用已知的涂覆技术将涂布溶液施加到皮肤刺穿元件(10)上,然后干燥。 将装置(12)施加到活动物(例如人)的皮肤上,导致微突起(10)刺穿角质层并将治疗有效剂量的药剂递送至动物。

    Reduction of skin sensitization in electrotransport drug delivery
    10.
    发明授权
    Reduction of skin sensitization in electrotransport drug delivery 失效
    减少电转运药物中的皮肤过敏

    公开(公告)号:US5995869A

    公开(公告)日:1999-11-30

    申请号:US872723

    申请日:1997-06-11

    IPC分类号: A61N1/30

    CPC分类号: A61N1/30

    摘要: A device and method are provided for reducing or preventing skin sensitization in electrotransport drug delivery. The method involves co-administration of a countersensitizing agent, comprising cis-urocanic acid or an analog thereof, with the drug delivered via electrotransport. Novel drug reservoirs and electrotransport drug delivery systems, formulated with a countersensitizing agent as described herein, are provided as well.

    摘要翻译: 提供了用于减少或预防电转运药物递送中的皮肤致敏的装置和方法。 该方法包括将包含顺式尿刊或其类似物的致敏剂与经由电转运递送的药物共同给药。 还提供了用本文所述的增敏剂配制的新型药物储库和电转运药物递送系统。